Citations

Clear

3138 citation(s) found for "Smith, AM".

Recommendations From the Society for the Advancement of Transplant Anesthesiology Fellowship Committee: Core Competencies and Milestones for the Kidney/Pancreas Component of Abdominal Organ Transplant Anesthesia Fellowship
Souki, Fouad G. , Chadha, Ryan , Planinsic, Raymond M. , Zerillo, Jeron , Nguyen, Christine , Smith, Natalie , Mandell, M. Susan , Sakai, Tetsuro , Nicolau‐Raducu, Ramona , Chadha, Ryan , Nguyen-Buckley, Christine

Mayo Clinic

Seminars in Cardiothoracic and Vascular Anesthesia | December 7, 2021 | Volume: 26 | Issue: 1 | Pages: 15-26

10.1177/10892532211058574 | PMID 34872395 Get It

The Society for the Advancement of Transplant Anesthesia (SATA) is dedicated to improving patient care in all facets of transplant anesthesia. The anesthesia fellowship training recommendations for thoracic transplantation (heart and lungs) and part of the abdominal organ transplantation (liver) have been presented in previous publications. The SATA Fellowship Committee has completed the remaining component of abdominal transplant anesthesia (kidney/pancreas) and has assembled core competencies and milestones derived from expert consensus to guide the education and overall preparation of trainees providing care for kidney/pancreas transplant recipients. These recommendations provide a comprehensive approach to pre-operative evaluation, vascular access procedures, advanced hemodynamic monitoring, assessment of coagulation and metabolic abnormalities, operative techniques, and post-operative pain control. As such, this document supplements the current liver/hepatic transplant anesthesia fellowship training programs to include all aspects of “Abdominal Organ Transplant Anesthesia” recommended knowledge.
The Effect of Curative Treatment on Hyperglycemia in Patients With Cushing Syndrome
Herndon, Justine , Kaur, Ravinder Jeet , Romportl, Mark, Smith, Emily, Koenigs, Amy, Partlow, Brenda, Arteaga, Leonardo, Bancos, Irina , Smith, Emily, Bancos, Irina

Mayo Clinic

Journal of the Endocrine Society | December 5, 2021 | Volume: 6 | Issue: 1 | Pages: No page available

10.1210/jendso/bvab169 | PMID 34988348 Get It

Abstract Context Hyperglycemia is a common complication of Cushing syndrome (CS). Objective We aimed to determine the impact of curative procedure on hyperglycemia and its management in patients with CS. Methods This retrospective longitudinal cohort study took place 2000 to 2019 in a referral center among adults with endogenous CS and hyperglycemia. Main outcome measures included glycated hemoglobin A1c (HbA1c), intensity of hyperglycemia therapy, and improvement of hyperglycemia. Results In 174 patients with CS (pituitary in 106, ectopic in 25, adrenal in 43), baseline median HbA1c was 6.9% (range, 4.9-13.1), with 41 (24%) patients not on any therapy for hyperglycemia, 93 (52%) on oral medications, and 64 (37%) on insulin (median daily units of 58; range, 10-360). Following CS remission, at the end of follow-up (median 10.5 months), 37 (21%) patients demonstrated resolution of hyperglycemia, 82 (47%) demonstrated improvement, and 55 (32%) had no change or worsening in hyperglycemia. At the end of follow-up, HbA1c decreased by 0.84% (P < .001) and daily insulin dose decreased by a mean of 30 units (P < .001). Biochemical hypercortisolism severity score (severe vs moderate/mild: odds ratio [OR] of 2.4 [95% CI, 1.1-4.9]), and CS subtype (nonadrenal vs adrenal: OR of 2.9 [95% CI, 1.3-6.4]), but not type of hyperglycemia (diabetes vs prediabetes: OR of 2.1 [0.9-4.9]) were associated with hyperglycemia improvement at the end of follow-up. Conclusion Two-thirds of patients with CS and hyperglycemia demonstrate resolution or improvement of hyperglycemia after a curative procedure. Close monitoring during CS recovery is needed to ensure appropriate therapy modification.
Socioeconomic and demographic factors in the diagnosis and treatment of Chiari malformation type I and syringomyelia
Akbari, Syed Hassan A., Rizvi, Asad A., CreveCoeur, Travis S., Han, Rowland H., Greenberg, Jacob K., Torner, James, Brockmeyer, Douglas L., Wellons, John C., Leonard, Jeffrey R., Mangano, Francesco T., Johnston, James M., Shah, Manish N., Iskandar, Bermans J., Ahmed, Raheel, Tuite, Gerald F., Kaufman, Bruce A., Daniels, David J., Jackson, Eric M., Grant, Gerald A., Powers, Alexander K., Couture, Daniel E., Adelson, P. David, Alden, Tord D., Aldana, Philipp R., Anderson, Richard C. E., Selden, Nathan R., Bierbrauer, Karin, Boydston, William, Chern, Joshua J., Whitehead, William E., Dauser, Robert C., Ellenbogen, Richard G., Ojemann, Jeffrey G., Fuchs, Herbert E., Guillaume, Daniel J., Hankinson, Todd C., O’Neill, Brent R., Iantosca, Mark, Oakes, W. Jerry, Keating, Robert F., Klimo, Paul, Muhlbauer, Michael S., McComb, J. Gordon, Menezes, Arnold H., Khan, Nickalus R., Niazi, Toba N., Ragheb, John, Shannon, Chevis N., Smith, Jodi L., Ackerman, Laurie L., Jea, Andrew H., Maher, Cormac O., Narayan, Prithvi, Albert, Gregory W., Stone, Scellig S. D., Baird, Lissa C., Gross, Naina L., Durham, Susan R., Greene, Stephanie, McKinstry, Robert C., Shimony, Joshua S., Strahle, Jennifer M., Smyth, Matthew D., Dacey, Ralph G., Park, Tae Sung, Limbrick, David D., Torner, James C. , Greene, Stephanie , Jackson, Eric M. , Stone, Scellig , Akbari, Syed Hassan A., Rizvi, Asad A., CreveCoeur, Travis S., Han, Rowland H., Greenberg, Jacob K., Brockmeyer, Douglas L., Wellons, John C., Leonard, Jeffrey R., Mangano, Francesco T., Johnston, James M., Shah, Manish N., Iskandar, Bermans J., Ahmed, Raheel, Tuite, Gerald F., Kaufman, Bruce A., Daniels, David J., Jackson, Eric M., Grant, Gerald A., Powers, Alexander K., Couture, Daniel E., Adelson, P. David, Alden, Tord D., Aldana, Philipp R., Anderson, Richard C. E., Selden, Nathan R., Bierbrauer, Karin, Boydston, William, Chern, Joshua J., Whitehead, William E., Dauser, Robert C., Ellenbogen, Richard G., Ojemann, Jeffrey G., Fuchs, Herbert E., Guillaume, Daniel J., Hankinson, Todd C., O’Neill, Brent R., Iantosca, Mark, Oakes, W. Jerry, Keating, Robert F., Klimo, Paul, Muhlbauer, Michael S., McComb, J. Gordon, Menezes, Arnold H., Khan, Nickalus R., Niazi, Toba N., Ragheb, John, Shannon, Chevis N., Smith, Jodi L., Ackerman, Laurie L., Jea, Andrew H., Maher, Cormac O., Narayan, Prithvi, Albert, Gregory W., Stone, Scellig S. D., Baird, Lissa C., Gross, Naina L., Durham, Susan R., Greene, Stephanie, McKinstry, Robert C., Shimony, Joshua S., Strahle, Jennifer M., Smyth, Matthew D., Dacey, Ralph G., Park, Tae Sung, Limbrick, David D.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | December 3, 2021 | Volume: 29 | Issue: 3 | Pages: 288-297

10.3171/2021.9.peds2185 | PMID 34861643 Get It

OBJECTIVE The goal of this study was to assess the social determinants that influence access and outcomes for pediatric neurosurgical care for patients with Chiari malformation type I (CM-I) and syringomyelia (SM). METHODS The authors used retro- and prospective components of the Park-Reeves Syringomyelia Research Consortium database to identify pediatric patients with CM-I and SM who received surgical treatment and had at least 1 year of follow-up data. Race, ethnicity, and insurance status were used as comparators for preoperative, treatment, and postoperative characteristics and outcomes. RESULTS A total of 637 patients met inclusion criteria, and race or ethnicity data were available for 603 (94.7%) patients. A total of 463 (76.8%) were non-Hispanic White (NHW) and 140 (23.2%) were non-White. The non-White patients were older at diagnosis (p = 0.002) and were more likely to have an individualized education plan (p < 0.01). More non-White than NHW patients presented with cerebellar and cranial nerve deficits (i.e., gait ataxia [p = 0.028], nystagmus [p = 0.002], dysconjugate gaze [p = 0.03], hearing loss [p = 0.003], gait instability [p = 0.003], tremor [p = 0.021], or dysmetria [p < 0.001]). Non-White patients had higher rates of skull malformation (p = 0.004), platybasia (p = 0.002), and basilar invagination (p = 0.036). Non-White patients were more likely to be treated at low-volume centers than at high-volume centers (38.7% vs 15.2%; p < 0.01). Non-White patients were older at the time of surgery (p = 0.001) and had longer operative times (p < 0.001), higher estimated blood loss (p < 0.001), and a longer hospital stay (p = 0.04). There were no major group differences in terms of treatments performed or complications. The majority of subjects used private insurance (440, 71.5%), whereas 175 (28.5%) were using Medicaid or self-pay. Private insurance was used in 42.2% of non-White patients compared to 79.8% of NHW patients (p < 0.01). There were no major differences in presentation, treatment, or outcome between insurance groups. In multivariate modeling, non-White patients were more likely to present at an older age after controlling for sex and insurance status (p < 0.01). Non-White and male patients had a longer duration of symptoms before reaching diagnosis (p = 0.033 and 0.004, respectively). CONCLUSIONS Socioeconomic and demographic factors appear to influence the presentation and management of patients with CM-I and SM. Race is associated with age and timing of diagnosis as well as operating room time, estimated blood loss, and length of hospital stay. This exploration of socioeconomic and demographic barriers to care will be useful in understanding how to improve access to pediatric neurosurgical care for patients with CM-I and SM.
Author response: Histone deacetylase 3 represses cholesterol efflux during CD4+ T-cell activation
Lama, Jyoti , Kizerwetter, Monika , Shapiro, Michael J. , McCue, Shaylene , Kennedy, Madeleine M, Rajcula, Matthew, Wilfahrt, Drew N. , Philips, Rachael L. , Shapiro, Michael Jeremy, Kennedy, Madeleine, Zeng, Hu , Shapiro, Virginia Smith

Mayo Clinic

No container title available | December 2, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.70978.sa2 Get It

P.155: Altered T Cell Compartment in Type 1 Diabetes With End Stage Renal Disease
Rizvi, Shafaq R., Kaur, Ravinder Jeet , Dadlani, Vikash, Almodallal, Yahya , Reid, Corey, Kukla, Aleksandra , Akha, Amir A. Sadighi, Kudva, Yogish C. , Rizvi, Shafaq, Smith, Byron H. , Kremers, Walter K. , Stegall, Mark D.

Mayo Clinic

Transplantation | November 28, 2021 | Volume: 105 | Issue: 12S1 | Pages: S63-S64

10.1097/01.tp.0000804676.91579.8b Get It

P.157: NK and B Cell Subset Assessment in Type I Diabetes Patients on Waitlist for Pancreas Transplantation
Rizvi, Shafaq R., Kaur, Ravinder Jeet , Dadlani, Vikash, Almodallal, Yahya , Reid, Corey, Kukla, Aleksandra , Akha, Amir A. Sadighi, Kudva, Yogish C. , Rizvi, Shafaq, Smith, Byron H. , Kremers, Walter K. , Stegall, Mark D.

Mayo Clinic

Transplantation | November 28, 2021 | Volume: 105 | Issue: 12S1 | Pages: S65-S65

10.1097/01.tp.0000804684.04172.49 Get It

P.140: Impact of Successful Pancreas Transplantation on Patient Reported Hypoglycemia Outcomes
Kaur, Ravinder Jeet , Rizvi, Shafaq R., Reid, Corey, Johnson, Bradley K. , McCrady-Spitzer, Shelly , Dean, Patrick G. , Kukla, Aleksandra , Kudva, Yogish C. , Rizvi, Shafaq, Smith, Byron H. , Kremers, Walter K. , Stegall, Mark D.

Mayo Clinic

Transplantation | November 28, 2021 | Volume: 105 | Issue: 12S1 | Pages: S57-S57

10.1097/01.tp.0000804624.59941.7c Get It

P.138: Patients Report Improved Diabetes Distress After Successful Pancreas Transplantation
Kaur, Ravinder Jeet , Rizvi, Shafaq R., Reid, Corey, Johnson, Bradley K. , McCrady-Spitzer, Shelly , Dean, Patrick G. , Kukla, Aleksandra , Kudva, Yogish C. , Rizvi, Shafaq, Smith, Byron H. , Kremers, Walter K. , Stegall, Mark D.

Mayo Clinic

Transplantation | November 28, 2021 | Volume: 105 | Issue: 12S1 | Pages: S56-S56

10.1097/01.tp.0000804616.86766.b2 Get It

Identifying opportunities to advance health equity in interventional cardiology: Structural heart disease
Allana, Salman , Alli, Olueseun, Coylewright, Megan , Horne, Aaron, Ijioma, Nkechinyere , Kadavath, Sabeeda , Pineda, Andrés M. , Sanchez, Carlos E. , Schreiber, Theodore , Shah, Atman P. , Smith, Conrad, Young, Michael N. , Krishnan, Sandeep , Allana, Salman S , Ijioma, Nkechi , Pineda, Andres , Sanchez, Carlos , Suradi, Hussam , Young, Michael , Krishnan, Sandeep K , Alkhouli, Mohamad , Sylvia, Kristyn E.

Mayo Clinic

Catheterization and Cardiovascular Interventions | November 27, 2021 | Volume: 99 | Issue: 4 | Pages: 1165-1171

10.1002/ccd.30021 | PMID 34837459 Get It

AbstractHealth care practices are influenced by variety of factors. These factors that include social determinants, race and ethnicity, and gender not only affect access to health care but can also affect quality of care and patient outcomes. These are a source of health care disparities. This article acknowledges that these disparities exist in getting optimal care in structural heart disease, reviews the literature and proposes steps that can help reduce these disparities on personal and committee levels.
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021
Gradishar, William J. , Moran, Meena S. , Abraham, Jame , Aft, Rebecca , Allison, Kimberly H. , Blair, Sarah L. , Burstein, Harold J. , Dang, Chau T. , Goldstein, Lori J. , Hurvitz, Sara A. , Isakoff, Steven J. , Jankowitz, Rachel C. , Javid, Sara H. , Leitch, Marilyn , Lyons, Janice A., Matro, Jennifer M. , Patel, Sameer A. , Pierce, Lori J. , Sitapati, Amy M. , Smith, Mary Lou , Stringer-Reasor, Erica , Telli, Melinda L. , Wisinski, Kari B. , Burns, Jennifer L. , Agnese, Doreen Marie , Elias, Anthony , Giordano, Sharon H. , Goetz, Matthew P. , Krishnamurthy, Jairam , Mayer, Ingrid A. , Mortimer, Joanne , O'Regan, Ruth M , Rugo, Hope S. , Smith, Karen L. , Soliman, Hatem Hussein , Ward, John Headley , Young, Jessica S. , Kumar, Rashmi , Telli, Melinda L

Mayo Clinic

Journal of the National Comprehensive Cancer Network | November 26, 2021 | Volume: 19 | Issue: 5 | Pages: 484-493

10.6004/jnccn.2021.0023 | PMID 34794122 Get It

The NCCN Guidelines for Breast Cancer include up-to-date guidelines for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, male breast cancer, and breast cancer during pregnancy. These guidelines are developed by a multidisciplinary panel of representatives from NCCN Member Institutions with breast cancer–focused expertise in the fields of medical oncology, surgical oncology, radiation oncology, pathology, reconstructive surgery, and patient advocacy. These NCCN Guidelines Insights focus on the most recent updates to recommendations for adjuvant systemic therapy in patients with nonmetastatic, early-stage, hormone receptor–positive, HER2-negative breast cancer.